PATENT CLAIM ANALYSIS

Application Number: 15955523
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "265100"]

Abstract:
The present invention relates to a pyrrolopyrimidine compound as TLR7 agonist, and particularly relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation process thereof, a pharmaceutical composition containing such compounds and use thereof for manufacturing a medicament against viral infection.

Claim (Index 28):
The method according to  claim 27 , wherein the viral infection is the infection of dengue fever virus, yellow fever virus, west nile virus, Japanese encephalitis virus, tick borne encephalitis virus, Kunjin virus, Murray Valley encephalitis virus, St Louis encephalitis virus, Omsk Hemorrhagic Fever virus, bovine viral diarrhea virus, Zika virus or hepatitis virus.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 91.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15503977', '15319726', '12334371', '13470122', '16096848']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8149097851716087
- 35 USC 102 Novelty (BERT): 0.5487718797064196
- Combined Prediction Score: 0.7882959946250899
- Mean Citation Score: 343.2720819999999
- Max Citation Score: 457.27234
- Similarity Product: 250.2010652367151

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test